Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › TX › Plano › NPI 1770514077
Clinic

Texas Health Presbyterian Hospital Plano

Texas Health Presbyterian Hospital Plano was paid $2.32M by Medicaid between Dec 2019 and Nov 2024, across 62 billing codes. Its largest line is 99284, emergency room visit (serious) — 29% of everything it billed.

33Billing provider infoTEXAS HEALTH PRESBYTERIAN HOSPITAL PLANO
PLANO, TX 75093
33aNPI1770514077assigned 07/05/2006
28Total paid$2.32M
24GClaims56,765
24DCodes billed62
24AFirst – last monthDec 2019 – Nov 2024
Compared with peers

Next to other Ambulatory Surgical Clinic/Center providers in Texas

Rank by total paid#111 of 320
Median peer was paid$205K
This provider vs. median11×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official MINCHER, JEFF controls 13+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$50K$100K$150K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201935$88.69
2020748$40K
202113,312$473K
202218,983$812K
202315,057$703K
2024incomplete8,630$288K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 29% 4,260 3,851 $679K
H0035 Mental health partial hospitalization, treatment, less than 24 hours 26% 1,602 328 $598K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 11% 1,213 1,125 $249K
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 8.9% 4,321 4,054 $205K
74177 Computed tomography, abdomen and pelvis; with contrast material 3.6% 587 547 $83K
80053 Comprehensive metabolic panel 3.5% 6,430 5,535 $82K
87631 3.3% 948 898 $77K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.9% 6,957 5,754 $44K
90853 Group psychotherapy (other than of a multiple-family group) 1.9% 122 28 $44K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.9% 1,768 1,590 $43K
70450 Computed tomography, head or brain; without contrast material 1.4% 678 636 $33K
71045 Radiologic examination, chest; single view 1.1% 1,506 1,394 $26K
50 more codes
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 1.1% 2,056 $25K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 191 $9K
84703 <1% 1,597 $9K
J7030 Infusion, normal saline solution , 1000 cc <1% 2,538 $9K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 864 $8K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 1,509 $8K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 135 $7K
96375 Therapeutic injection; each additional sequential IV push <1% 1,193 $7K
84484 <1% 1,492 $7K
81001 <1% 2,704 $6K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 163 $6K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 127 $5K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 250 $5K
96361 Intravenous infusion, hydration; each additional hour <1% 593 $4K
93976 <1% 78 $4K
83690 <1% 1,415 $4K
76801 <1% 45 $3K
83880 <1% 210 $3K
71046 Radiologic examination, chest; 2 views <1% 67 $3K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 80 $2K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 129 $2K
84702 <1% 152 $2K
87634 <1% 27 $2K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 1,653 $1K
J2270 Injection, morphine sulfate, up to 10 mg <1% 927 $1K
85610 <1% 742 $1K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 17 $1K
72125 Computed tomography, cervical spine; without contrast material <1% 30 $898.84
96376 <1% 120 $738.38
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 27 $704.38
85730 <1% 350 $695.38
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 768 $635.11
85379 <1% 111 $538.44
83735 <1% 246 $532.77
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 15 $511.84
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 151 $507.59
80048 Basic metabolic panel (calcium, ionized) <1% 179 $476.17
87086 Culture, bacterial; quantitative colony count, urine <1% 91 $428.76
83605 <1% 46 $353.93
86901 <1% 132 $221.95
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 16 $146.27
J7120 Ringers lactate infusion, up to 1000 cc <1% 108 $142.35
J3010 Injection, fentanyl citrate, 0.1 mg <1% 115 $134.88
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 15 $127.29
36415 Collection of venous blood by venipuncture <1% 1,790 $83.80
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 43 $77.66
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 12 $65.32
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 43 $22.53
A9270 Non-covered item or service 0% 978 $0.00
J2704 Injection, propofol, 10 mg 0% 33 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMINCHER, JEFF (SENIOR VP REVENUE CYCLE)
Same official

Other billing entities under MINCHER, JEFF

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.